These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 9530894

  • 1. Biliary tree malignancies.
    Erickson BA, Nag S.
    J Surg Oncol; 1998 Mar; 67(3):203-10. PubMed ID: 9530894
    [Abstract] [Full Text] [Related]

  • 2. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
    Takamura A, Saito H, Kamada T, Hiramatsu K, Takeuchi S, Hasegawa M, Miyamoto N.
    Int J Radiat Oncol Biol Phys; 2003 Dec 01; 57(5):1357-65. PubMed ID: 14630274
    [Abstract] [Full Text] [Related]

  • 3. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy.
    Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI.
    Int J Radiat Oncol Biol Phys; 1996 Mar 01; 34(4):767-74. PubMed ID: 8598352
    [Abstract] [Full Text] [Related]

  • 4. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
    Shin HS, Seong J, Kim WC, Lee HS, Moon SR, Lee IJ, Lee KK, Park KR, Suh CO, Kim GE.
    Int J Radiat Oncol Biol Phys; 2003 Sep 01; 57(1):105-12. PubMed ID: 12909222
    [Abstract] [Full Text] [Related]

  • 5. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas.
    Fritz P, Brambs HJ, Schraube P, Freund U, Berns C, Wannenmacher M.
    Int J Radiat Oncol Biol Phys; 1994 Jul 01; 29(4):855-61. PubMed ID: 8040034
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biliary tree malignancies: the University of Minnesota experience.
    Lee CK, Barrios BR, Bjarnason H.
    J Surg Oncol; 1997 Aug 01; 65(4):298-305. PubMed ID: 9274796
    [Abstract] [Full Text] [Related]

  • 8. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.
    González González D, Gouma DJ, Rauws EA, van Gulik TM, Bosma A, Koedooder C.
    Ann Oncol; 1999 Aug 01; 10 Suppl 4():215-20. PubMed ID: 10436826
    [Abstract] [Full Text] [Related]

  • 9. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P, Morganti AG, Dobelbower RR, Brizi G, Smaniotto D, Costamagna G, Cellini N, Marano P.
    Radiology; 1996 Jun 01; 199(3):861-6. PubMed ID: 8638018
    [Abstract] [Full Text] [Related]

  • 10. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P, Costamagna G, Dobelbower RR, Cellini N, Morganti AG, Mutignani M, Perri V, Brizi G, Marano P.
    Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):437-43. PubMed ID: 7538501
    [Abstract] [Full Text] [Related]

  • 11. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F, Clemente G, Mattiucci GC, Macchia G, Costamagna G, Giuliante F, Smaniotto D, Luzi S, Valentini V, Mutignani M, Nuzzo G, Cellini N, Morganti AG.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):483-8. PubMed ID: 16242254
    [Abstract] [Full Text] [Related]

  • 12. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
    Alden ME, Mohiuddin M.
    Int J Radiat Oncol Biol Phys; 1994 Mar 01; 28(4):945-51. PubMed ID: 8138448
    [Abstract] [Full Text] [Related]

  • 13. Combined modality treatment in unresectable extrahepatic biliary carcinoma.
    Morganti AG, Trodella L, Valentini V, Montemaggi P, Costamagna G, Smaniotto D, Luzi S, Ziccarelli P, Macchia G, Perri V, Mutignani M, Cellini N.
    Int J Radiat Oncol Biol Phys; 2000 Mar 01; 46(4):913-9. PubMed ID: 10705013
    [Abstract] [Full Text] [Related]

  • 14. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
    Vallis KA, Benjamin IS, Munro AJ, Adam A, Foster CS, Williamson RC, Kerr GR, Price P.
    Radiother Oncol; 1996 Oct 01; 41(1):61-6. PubMed ID: 8961369
    [Abstract] [Full Text] [Related]

  • 15. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
    Leung JT, Kuan R.
    Australas Radiol; 1997 May 01; 41(2):151-4. PubMed ID: 9153812
    [Abstract] [Full Text] [Related]

  • 16. High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma.
    Lu JJ, Bains YS, Abdel-Wahab M, Brandon AH, Wolfson AH, Raub WA, Wilkinson CM, Markoe AM.
    Cancer J; 2002 May 01; 8(1):74-8. PubMed ID: 11895206
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
    Nomura M, Yamakado K, Nomoto Y, Nakatsuka A, Ii N, Shoji K, Takeda K.
    Int J Oncol; 2002 Feb 01; 20(2):325-31. PubMed ID: 11788896
    [Abstract] [Full Text] [Related]

  • 18. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma.
    Simmons DT, Baron TH, Petersen BT, Gostout CJ, Haddock MG, Gores GJ, Yeakel PD, Topazian MD, Levy MJ.
    Am J Gastroenterol; 2006 Aug 01; 101(8):1792-6. PubMed ID: 16780552
    [Abstract] [Full Text] [Related]

  • 19. Postoperative endoscopic retrograde high dose-rate brachytherapy for cholangiocarcinoma.
    Ove R, Kennedy A, Darwin P, Haluszka O.
    Am J Clin Oncol; 2000 Dec 01; 23(6):559-61. PubMed ID: 11202795
    [Abstract] [Full Text] [Related]

  • 20. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
    Autorino R, Bisiello S, Pappalardi B, Privitera V, Buwenge M, Piccolo F, Masciocchi C, Tagliaferri L, Macchia G, Curti CD, Luppatteli M, Cerrotta A, Morganti AG, Valentini V, Mattiucci G.
    Anticancer Res; 2020 Jun 01; 40(6):3417-3421. PubMed ID: 32487639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.